191 related articles for article (PubMed ID: 26604159)
21. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait.
Omu AE; Al-Harmi J; Vedi HL; Mlechkova L; Sayed AF; Al-Ragum NS
Med Princ Pract; 2008; 17(3):227-32. PubMed ID: 18408392
[TBL] [Abstract][Full Text] [Related]
22. An audit of the use of magnesium sulphate in severe pre-eclampsia and eclampsia.
Singh J; O'Donovan M; Coulter-Smith SD; Geary M
J Obstet Gynaecol; 2005 Jan; 25(1):15-7. PubMed ID: 16147685
[TBL] [Abstract][Full Text] [Related]
23. Low-dose magnesium sulphate in the control of eclamptic fits: a randomized controlled trial.
Abdul MA; Nasir UI; Khan N; Yusuf MD
Arch Gynecol Obstet; 2013 Jan; 287(1):43-6. PubMed ID: 22930148
[TBL] [Abstract][Full Text] [Related]
24. Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial.
Vigil-De Gracia P; Ramirez R; Durán Y; Quintero A
BMC Pregnancy Childbirth; 2017 Jul; 17(1):241. PubMed ID: 28738788
[TBL] [Abstract][Full Text] [Related]
25. Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia: a randomized controlled trial.
Ehrenberg HM; Mercer BM
Obstet Gynecol; 2006 Oct; 108(4):833-8. PubMed ID: 17012443
[TBL] [Abstract][Full Text] [Related]
26. Ionized and total magnesium concentration in patients with severe preeclampsia-eclampsia undergoing magnesium sulfate therapy.
Aali BS; Khazaeli P; Ghasemi F
J Obstet Gynaecol Res; 2007 Apr; 33(2):138-43. PubMed ID: 17441885
[TBL] [Abstract][Full Text] [Related]
27. A comparison between the two methods of magnesium sulfate administration for duration of 12 versus 24 h after delivery in patients with severe preeclampsia.
Kashanian M; Koohpayehzadeh J; Sheikhansari N; Bararpour F; Sahraian G; Asadolla S
J Matern Fetal Neonatal Med; 2016; 29(14):2282-7. PubMed ID: 26364667
[TBL] [Abstract][Full Text] [Related]
28. Intravenous magnesium sulfate in the management of severe pre-eclampsia: A randomized study of 12-hour versus 24-hour maintenance dose.
Unwaha EA; Bello FA; Bello OO; Oladokun A
Int J Gynaecol Obstet; 2020 Apr; 149(1):37-42. PubMed ID: 31833059
[TBL] [Abstract][Full Text] [Related]
29. Maternal and perinatal outcome of severe pre-eclampsia in Enugu, Nigeria after introduction of Magnesium sulfate.
Ugwu EO; Dim CC; Okonkwo CD; Nwankwo TO
Niger J Clin Pract; 2011; 14(4):418-21. PubMed ID: 22248941
[TBL] [Abstract][Full Text] [Related]
30. Magnesium sulfate as an anticonvulsant in eclampsia.
Raman NV; Rao CA
Int J Gynaecol Obstet; 1995 Jun; 49(3):289-98. PubMed ID: 9764868
[TBL] [Abstract][Full Text] [Related]
31. Magnesium sulphate in the prophylaxis and treatment of eclampsia.
Noor S; Halimi M; Faiz NR; Gull F; Akbar N
J Ayub Med Coll Abbottabad; 2004; 16(2):50-4. PubMed ID: 15455618
[TBL] [Abstract][Full Text] [Related]
32. Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen.
Das M; Chaudhuri PR; Mondal BC; Mitra S; Bandyopadhyay D; Pramanik S
Indian J Pharmacol; 2015; 47(5):502-8. PubMed ID: 26600638
[TBL] [Abstract][Full Text] [Related]
33. Magnesium sulphate as an anticonvulsant in the management of eclampsia.
Ahmed R
J Coll Physicians Surg Pak; 2004 Oct; 14(10):605-7. PubMed ID: 15456550
[TBL] [Abstract][Full Text] [Related]
34. Management of eclampsia at Assiut University Hospital, Egypt.
Abd El Aal DE; Shahin AY
Int J Gynaecol Obstet; 2012 Mar; 116(3):232-6. PubMed ID: 22189064
[TBL] [Abstract][Full Text] [Related]
35. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
Riaz M; Porat R; Brodsky NL; Hurt H
J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
[TBL] [Abstract][Full Text] [Related]
36. Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia.
Sibai BM; Lipshitz J; Anderson GD; Dilts PV
Obstet Gynecol; 1981 Feb; 57(2):199-202. PubMed ID: 7465124
[TBL] [Abstract][Full Text] [Related]
37. A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use.
McDonald SD; Lutsiv O; Dzaja N; Duley L
Int J Gynaecol Obstet; 2012 Aug; 118(2):90-6. PubMed ID: 22703834
[TBL] [Abstract][Full Text] [Related]
38. Repeat postpartum magnesium sulfate administration for seizure prophylaxis: is there a patient profile predictive of need for additional therapy?
Isler CM; Barrilleaux PS; Rinehart BK; Magann EF; Martin JN
J Matern Fetal Neonatal Med; 2002 Feb; 11(2):75-9. PubMed ID: 12375546
[TBL] [Abstract][Full Text] [Related]
39. Recurrent Seizures in 2 Patients with Magnesium Sulfate-Treated Eclampsia at a Secondary Hospital.
Harsono AAH; Achmadi A; Aldika Akbar MI; Joewono HT
Am J Case Rep; 2018 Sep; 19():1129-1134. PubMed ID: 30250014
[TBL] [Abstract][Full Text] [Related]
40. An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management.
Smith JM; Lowe RF; Fullerton J; Currie SM; Harris L; Felker-Kantor E
BMC Pregnancy Childbirth; 2013 Feb; 13():34. PubMed ID: 23383864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
